Event Details
NRx Pharmaceuticals Discusses FDA First Cycle Review
August 10, 2026 8:30 AM EDT
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discusses the FDA's completion of first-cycle review of the Company's ANDA for preservative-free ketamine.
Corporate Presentation
